Jason Eng
@Dymon Asia Capital (singapore) Pte. Ltd.
Latest period2024 - Q3ReportedManaged Assets$369.283MTotal holdings60
Assets growth rate-1.7%Assets growth rate (2-Q avg)-9.3%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Dymon Asia Capital (singapore) Pte. Ltd.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 60 positions.
Assets under management
The assets under management (AUM) of Dymon Asia Capital (singapore) Pte. Ltd. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 369.283M in assets, with a quarterly growth rate of -1.7% and a 2-quarter average growth rate of -9.3%. The portfolio is managed by Jason Eng, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
BZKanzhun Limited
| 3.3% | $12.152M 700,000 shares@ $17.36 avg price | Decreased -12.5% |
QQQInvesco Qqq Tr
| 2.73% | $10.054M↓ Put 20,600 shares@ $488.07 avg price | Decreased -56.63% |
CVSCvs Health Corp
| 1.96% | $7.231M↑ Call 115,000 shares@ $62.88 avg price | Decreased -51.42% |
CNQCanadian Nat Res Ltd
| 0.72% | $2.657M↑ Call 80,000 shares@ $33.21 avg price | Decreased -54.98% |
TSLATesla Inc
| 0.66% | $2.407M 9,200 shares@ $261.63 avg price | Decreased -53.78% |
TMOThermo Fisher Scientific Inc
| 0.42% | $1.546M 2,500 shares@ $618.57 avg price | Decreased -16.66% |
CTSHCognizant Technology Solutio
| 0.2% | $709,902 9,198 shares@ $77.19 avg price | Decreased -79.51% |
VKTXViking Therapeutics Inc
| 0.09% | $316,550 5,000 shares@ $63.31 avg price | Decreased -37.5% |